Cetirizine/pseudoephedrine - Beijing CoSci Med TechAlternative Names: Pseudoephedrine/cetirizine
Latest Information Update: 25 Jul 2016
At a glance
- Originator Beijing CoSci Med-Tech
- Class Antiallergics; Nonsedating antihistamines; Piperazines
- Mechanism of Action Alpha adrenergic receptor agonists; Histamine H1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Allergic rhinitis
Most Recent Events
- 25 Jul 2016 Investigation in Allergic rhinitis in China (PO)